Although adverse effects may occur, selective serotonin reuptake inhibitors are generally well tolerated in the elderly

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 5, 2009-05 ,pp. : 19-22

Adis International

Access to resources Recommend Favorite

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

By Dell’Osso Bernardo   Allen Andrea   Hollander Eric  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2727-2740

Informa Healthcare

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 10, 2016-12 ,pp. : 1290-1298

Bentham Science Publishers

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

By Silver Henry  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2053-2058

Informa Healthcare

Access to resources Recommend Favorite

Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients

By Ya-Chen Tina Shih   Bekele Nebiyou B.   Xu Ying  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 843-862

Adis International

Access to resources Recommend Favorite